Predicting response to CGRP-monoclonal antibodies in patients with migraine in Japan: a single-centre retrospective observational studyKeiko Ihara, Tsubasa Takizawa, Jin Nakahara et al.|The Journal of Headache and Pain|2023Cited by 82
Real-world evidence of galcanezumab for migraine treatment in Japan: a retrospective analysisTsubasa Takizawa, Jin Nakahara, Mamoru Shibata et al.|BMC Neurology|2022Cited by 67
Incidence of headache after COVID-19 vaccination in patients with history of headache: A cross-sectional studyKoji Sekiguchi, Tsubasa Takizawa, Narumi Watanabe et al.|Cephalalgia|2021Cited by 65
Flare of myasthenia gravis induced by COVID-19 vaccinesKei Ishizuchi, Shigeaki Suzuki, Haruhiko Motegi et al.|Journal of the Neurological Sciences|2022Cited by 28
Real-world evidence of fremanezumab for treating migraine in Japan: a retrospective studySeiya Ohtani, Tsubasa Takizawa, Narumi Watanabe et al.|BMC Neurology|2023Cited by 15